Bloomberg Audio Studios, podcasts, radio news. The Stock Movers Report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg Data. Let's take a look at some of the stock movers today.
We're joined by Bloomers Karmen, Ryan Key. Carmen, what are you looking at today? Yeah, So the first thing I'm looking at is Corse up to Therapeutics. This is ticker CORT. Shares are up about fifteen percent right now after the firm said that a trial for a drug in platinum resistant ovarian cancer met its overall survival primary endpoint and had a thirty five reduction in death risk compared to just another drug alone. Notice how I'm not trying to say the drug made.
Yes, that's too.
Many consonants in there. So the FDAY is also reviewing the drugs New Drug Application with a target date of July. If you assoom out on this chart too, I thought it was interesting. This is a big jump for shit for shares, But at the end of December it had a really sharp fall off, and that was because the FDA rejected the company's drug to treat a sort of
specific form of high blood pressure. So we're seeing a little bit of a rebound here, but it's you know, only at the highest sense December thirtieth.
So s long way off from the best levels, all right.
Next up, Yeah, so looking at Abbot Labs, it is the worst performer in the S and P right now, down seven zero point three percent worst cents July. So the medical devices firm reported, you know, a sales for the fourth quarter that fell short of estimates and also gave a first quarter earnings forecast that missed Wall Street estimates, sort of specifically after the company said it was forced to offer discounts on nutrition products to lure price conscious customers.
So I actually didn't know that it had sort of a nutrition section that does sort of protein drinks specifically for people on weight loss drugs. So seeing a little bit of weakness there, and analysts had already expected that there was going to be some weakness and more conservative guidance after the impact of COVID nineteen testing sales, but still, you know, less than expected here in shares down. Okay, one more yep. So another one I wanted to point
out is Arista Networks. So it's the top performer and the S and P. This is ticker a n E t up ten percent right now. I honestly don't have a great slam dunk reason for this, but you have to point it out. It's such a nice move. It's the best intra day since August for the company. It might be getting a little bit of a bid as part of a broader strength behind memory stocks. There was a not anything from Baird this morning, sort of putting it in that sector. We've seen some of those names
really take off this year. But also to be noted, a lot of those other constituents are down today, so like you know, sand Disk, Seagate, I think Western Digital is also a little bit down today. So we're looking for more reasons on that one. But a really stunning move from Arista Networks.
The stock Mover's report from bloom Ver Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.